IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13
about
'Entopy': local allergy paradigm.Phytochemical profiles and inhibitory effects of Tiger Milk mushroom (Lignosus rhinocerus) extract on ovalbumin-induced airway inflammation in a rodent model of asthmaAnimal models of asthma.Anti-Allergic Effect of Oroxylin A from Oroxylum indicum Using in vivo and in vitro Experiments.Immunopathogenesis of allergic asthma: more than the th2 hypothesis.Polydatin attenuated food allergy via store-operated calcium channels in mast cell.Effect of Shin'iseihaito on murine allergic reaction induced by nasal sensitization.Cytokine antagonists for the treatment of asthma: progress to date.Pitrakinra for asthma.The pharmacological modulation of allergen-induced asthma.Biologic therapy in asthma: entering the new age of personalized medicine.Pristimerin attenuates ovalbumin-induced allergic airway inflammation in mice.Targeting IL-4/IL-13 signaling to alleviate oral allergen-induced diarrheaPolyopes affinis alleviates airway inflammation in a murine model of allergic asthma.Antibody therapy for the management of severe asthma with eosinophilic inflammation.Hesperidin suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model.An IL-4/IL-13 dual antagonist reduces lung inflammation, airway hyperresponsiveness, and IgE production in mice.
P2860
Q34126805-C6C083F7-0E10-4E57-ACB4-5F2DFA007FA2Q36038729-2C428B14-27BE-433B-BE47-6B4BCA540AC2Q36854114-A4952E1C-AE87-46E0-AE7E-39B4C06B3A30Q36879189-2AAF995F-C8F9-417C-9B2F-FBC76F5DCF8CQ36962190-0FFCC7DB-7EB8-47BE-850E-C4D15DBED8D9Q36987837-F02AC056-2E82-4F28-9CF4-51768D2EA379Q37074762-5972A936-3F6D-4A29-BE9B-BE7FAB7C4AE3Q37583895-4BAE4F05-8ECA-40B2-A6EE-5D8C5AFEBB15Q37798003-EDCA92C2-D619-4BAD-9FF5-730C97810791Q38055384-2B670F8E-64BF-4FD7-A452-EE5E7072C009Q38202996-0C7140B8-D0B2-43C8-A7AE-D133B5E3A089Q39836311-7F4F6A98-6D5E-4C54-A45A-4A9B7F5A706DQ42739851-16D671DF-8EB2-4F08-AE7E-CA48FFBC7021Q43569379-3B777A70-6D7B-4E98-A114-5E21200D3F8FQ47773104-284E16FD-3254-4D90-ABF2-8BD98A17AD1AQ50283267-D4A22A97-50E9-4E1C-91F7-E3B478EDB6DAQ51754423-11C95F76-80CA-4872-8115-65035F05972B
P2860
IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13
description
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Juni 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/06/15)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/06/15)
@nl
наукова стаття, опублікована в червні 2005
@uk
مقالة علمية (نشرت في 15-6-2005)
@ar
name
IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13
@ast
IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13
@en
IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13
@nl
type
label
IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13
@ast
IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13
@en
IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13
@nl
prefLabel
IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13
@ast
IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13
@en
IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13
@nl
P2093
P921
P3181
P1476
IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13
@en
P2093
Cara M. M. Williams
Debra D. Donaldson
Marion T. Kasaian
Samuel J. Goldman
Susan C. Fish
P304
P3181
P356
10.4049/JIMMUNOL.174.12.7716
P407
P577
2005-06-15T00:00:00Z